Skip to main content
. 2006;5(8):689–702. doi: 10.1038/nrd2030

Figure 3. Comparison of the structures of cGMP, sildenafil and other PDE5 inhibitors.

Figure 3

a | The native substrate, cGMP. b | Sildenafil. c | Vardenafil and Tadalafil. cGMP, cyclic guanosine monophosphate; PDE5, phospho-diesterase type 5.

HHS Vulnerability Disclosure